Stay Updated with the Latest BeOne Medicines AG ONC News in Real Time
Find ONC news now at Meyka AI. Stay informed with the latest BeOne Medicines AG stocks updates, including price news, market analysis, and expert insights.
ASX Stocks Performance: CSL Climbs After Clinical Trial Update Boosts Healthcare Stocks
CSL shares surged nearly 7% on the ASX on Wednesday, July 29, 2026, leading a broad healthcare rally. The biotechnology giant climbed to around A$123.68 after unveiling plans for new clinical trials tied to its Horizon 2 manufacturing process. Healthcare stocks on the ASX jumped nearly 4% at midday, outpacing every other sector. The S&P/ASX…
TGA Warns GLP-1 Drugs Linked to Rare Eye Blindness July 25
Australia’s TGA warns GLP-1 drugs like Ozempic and Mounjaro linked to 36 cases of NAION, a rare eye disorder causing permanent blindness. No treatment available.
TGA Warns GLP-1 Drugs Like Ozempic Linked to Rare Eye Blindness July 25
Australia’s TGA warns GLP-1 drugs like Ozempic may cause NAION, a rare eye disorder leading to blindness. 36 cases reported. No treatment available. Patients urged to seek urgent medical attention if vision changes occur.
GLP-1 Weight Loss Drugs Linked to Hair Loss Risk, BMJ Study Finds July 24
New BMJ study finds GLP-1 weight loss drugs like Ozempic and Mounjaro linked to 37-68% higher hair loss risk. Researchers say the absolute risk remains low and hair loss is typically reversible.
Graham’s Family Dairy Recalls Milk at Tesco and Major UK Supermarkets Over Antibiotic Contamination
Graham’s Family Dairy recalls semi-skimmed milk at UK supermarkets including Tesco over possible antibiotic contamination. Bottles with best-before date 31 July 2026 affected. Full refunds available.
Novo Nordisk (NYSE: NVO) Sues Eli Lilly (NYSE: LLY) Over Allegedly Misleading GLP-1 Drug Advertising
On 21 July 2026, Novo Nordisk (NYSE: NVO) filed a lawsuit against Eli Lilly (NYSE: LLY), accusing its rival of misleading consumers through advertising that compares their blockbuster GLP-1 weight-loss drugs. The legal dispute comes as demand for obesity treatments keeps rising and competition between the two drugmakers becomes more intense. The outcome could affect…
US, EU, and Global Aid Flows Into Venezuela After Devastating 7.5 Earthquakes
Venezuela earthquakes on June 24 killed 4,700+ and displaced 21,000. US, EU, and global partners now delivering food, medical aid, and shelter to 40,000+ families through NGOs and military operations.
Dr Reddy’s (NSE: DRREDDY) Shares Tumble 7% After Semaglutide Launch Delay Due to API Quality Issue
Dr Reddy’s Laboratories shares tumbled nearly 7% on Thursday, July 9, 2026, on the NSE. The Hyderabad-based drugmaker disclosed a quality issue affecting its semaglutide active pharmaceutical ingredient. Certain batches were found out of specification, delaying commercial supplies indefinitely. Shares fell as much as 6.5% to an intraday low of ₹1,261.20 on the BSE. That…
Marksans Pharma (NSE: MARKSANS) Rises Nearly 4% After Acquiring Germany’s ABCnow GmbH
On July 8, 2026, Marksans Pharma (NSE: MARKSANS) climbed nearly 4% after announcing the acquisition of Germany-based ABCnow GmbH. The deal comes only weeks after the company’s expansion into the Netherlands and reflects its continued focus on growing in regulated international markets. Investors are now watching whether these overseas acquisitions will increase revenue, widen the…